2,534
Views
4
CrossRef citations to date
0
Altmetric
Article

Inosine induces acute hyperuricaemia in rhesus monkey (Macaca mulatta) as a potential disease animal model

ORCID Icon, , , , , ORCID Icon, & show all
Pages 173-180 | Received 03 Jan 2019, Accepted 29 Dec 2020, Published online: 14 Mar 2021

References

  • Abeles AM. 2015. Hyperuricemia, gout, and cardiovascular disease: an update. Curr Rheumatol Rep. 17(3):13–17.
  • Diaz-Torne C, Perez-Herrero N, Perez-Ruiz F. 2015. New medications in development for the treatment of hyperuricemia of gout. Curr Opin Rheumatol. 27(2):164–169.
  • Du H, Chen S, Wang Y, Xu L. 1998. The epidemiology of hyperuricemia and gout in a community population of Huangpu district in Shanghai. Chin Med J. 111:228–230.
  • Etani R, Kataoka T, Kanzaki N, Sakoda A, Tanaka H, Ishimori Y, Mitsunobu F, Yamaoka K. 2016. Difference in the action mechanism of radon inhalation and radon hot spring water drinking in suppression of hyperuricemia in mice. J Radiat Res. 57(3):250–257.
  • Fanelli GM, Beyer KH. 1974. Uric acid in nonhuman primates with special reference to its renal transport. Annu Rev Pharmacol. 14(1):355–364.
  • Feig DI. 2014. Serum uric acid and the risk of hypertension and chronic kidney disease. Curr Opin Rheumatol. 26(2):176–185.
  • Fujiwara S, Nakashima K, Noguchi T. 1987. Insoluble uricase in liver peroxisomes of Old World monkeys. Comp Biochem Physiol B. 88(2):467–469.
  • Hahn K, Kanbay M, Lanaspa MA, Johnson RJ, Ejaz AA. 2017. Serum uric acid and acute kidney injury: a mini review. J Adv Res. 8(5):529–536.
  • Hosomi A, Nakanishi T, Fujita T, Tamai I. 2012. Extra-renal elimination of uric acid via intestinal efflux transporter BCRP/ABCG2. PLoS One. 7(2):e30456.
  • Ishikawa T, Aw W, Kaneko K. 2013. Metabolic interactions of purine derivatives with human ABC transporter ABCG2: genetic testing to assess gout risk. Pharmaceuticals (Basel). 6(11):1347–1360.
  • Liu R, Han C, Wu D, Xia X, Gu J, Guan H, Shan Z, Teng W. 2015. Prevalence of hyperuricemia and gout in mainland China from 2000 to 2014: a systematic review and meta-analysis. Biomed Res Int. 2015:762820.
  • Magness CL, Fellin PC, Thomas MJ, Korth MJ, Agy MB, Proll SC, Fitzgibbon M, Scherer CA, Miner DG, Katze MG, et al. 2005. Analysis of the Macaca mulatta transcriptome and the sequence divergence between Macaca and human. Genome Biol. 6(7):R60.
  • Mikuls TR, Farrar JT, Bilker WB, Fernandes S, Schumacher HR Jr, Saag KG. 2005. Gout epidemiology: results from the UK General Practice Research Database, 1990–1999. Ann Rheum Dis. 64(2):267–272.
  • Mori G, Percudani R. 2016. Recent advances in urate metabolism. G Ital Nefrol. 33(S68):gin/33.S68.9.
  • Oda M, Satta Y, Takenaka O, Takahata N. 2002. Loss of urate oxidase activity in hominoids and its evolutionary implications. Mol Biol Evol. 19(5):640–653.
  • Roddy E, Choi HK. 2014. Epidemiology of gout. Rheum Dis Clin North Am. 40(2):155–175.
  • Rodwell VW, Kennelly PJ. 2003. Enzymes: regulation of activities. In: Harper’s illustrated biochemistry. 26th ed. USA: McGraw-Hill Companies, Inc. Press; p. 72–79.
  • Stavric B, Clayman S, Gadd RE, Hebert D. 1975. Some in vivo effects in the rat induced by chlorprothixene and potassium oxonate. Pharmacol Res Commun. 7(2):117–124.
  • Sun Z. 1994. Long-term use of inosine causes asymptomatic hyperuricemia. New Med. 9:475.
  • Woodward OM, Kottgen A, Coresh J, Boerwinkle E, Guggino WB, Kottgen M. 2009. Identification of a urate transporter, ABCG2, with a common functional polymorphism causing gout. Proc Natl Acad Sci USA. 106(25):10338–10342.
  • Wright AF, Rudan I, Hastie ND, Campbell H. 2010. A 'complexity' of urate transporters. Kidney Int. 78(5):446–452.
  • Xu L, Shi Y, Zhuang S, Liu N. 2017. Recent advances on uric acid transporters. Oncotarget. 8(59):100852–100862.
  • Yan G, Zhang G, Fang X, Zhang Y, Li C, Ling F, Cooper DN, Li Q, Li Y, van Gool AJ, et al. 2011. Genome sequencing and comparison of two nonhuman primate animal models, the cynomolgus and Chinese rhesus macaques. Nat Biotechnol. 29(11):1019–1023.
  • Yang X, Hung X, Tian Z, Wang P, Li P, Zhang J. 2017. Establishment of a novel hyperuricemia animal model using mice and assessment of hyporuricemia action of PNP inhibitor ulodesine. Chin Pharmacol Bull. 33:882–885.
  • Yun Y, Yin H, Gao Z, Li Y, Gao T, Duan J, Yang R, Dong X, Zhang L, Duan W. 2017. Intestinal tract is an important organ for lowering serum uric acid in rats. PLoS One. 12(12):e0190194.
  • Zhu Y, Peng X, Ling G. 2017. An update on the animal models in hyperuricaemia research. Clin Exp Rheumatol. 35(5):860–864.